Table of Contents
ISRN Neurology
Volume 2013 (2013), Article ID 748127, 8 pages
http://dx.doi.org/10.1155/2013/748127
Clinical Study

Dynamics of B-Cell Populations in CSF and Blood in Patients Treated with a Combination of Rituximab and Mitoxantrone

1St. Petersburg’s Center of MS and Autoimmune Diseases, City Hospital N31, Saint Petersburg, Russia
2Department of Rheumatology, Federal Clinical Center of Heart, Blood and Endocrinology, Saint Petersburg, Russia
3Laboratory of Autoimmune Diagnostics, Saint-Petersburg Pavlov Medical University, Saint Petersburg, Russia
4Department of Neurology, Leningrad Region Hospital, Saint Petersburg, Russia
5Neuroimmunology Group, Blizard Institute, Great Britain, UK
6Laboratory of Immunology, Pasteur Institute for Microbiology and Epidemiology, Saint Petersburg, Russia
7Department of Neurology, Saint-Petersburg Pavlov Medical University, Saint Petersburg, Russia
8Department of Neurology and Neurosurgery and Department of Microbiology and Immunology, McGill University, Montreal, QC, Canada

Received 16 July 2013; Accepted 9 August 2013

Academic Editors: R. Beschorner and R. Saponara

Copyright © 2013 Evgeniy Evdoshenko et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

How to Cite this Article

Evgeniy Evdoshenko, Alexey Maslyanskiy, Sergey Lapin, et al., “Dynamics of B-Cell Populations in CSF and Blood in Patients Treated with a Combination of Rituximab and Mitoxantrone,” ISRN Neurology, vol. 2013, Article ID 748127, 8 pages, 2013. doi:10.1155/2013/748127